Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Diabetes Risk & Digital Health Programs

Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by 2034, growing at a 7.2% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of insulin resistance, sedentary lifestyles, obesity, and increased screening initiatives are fueling substantial market growth.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72063

Market Summary
The Prediabetes Market is expanding rapidly as healthcare systems prioritize early intervention to prevent the progression to type 2 diabetes. Prediabetes-characterized by impaired glucose tolerance or impaired fasting glucose-affects hundreds of millions globally, many of whom remain undiagnosed.

Market growth is driven by increased adoption of diagnostic testing (HbA1c, fasting glucose, oral glucose tolerance tests), lifestyle modification programs, antihyperglycemic medications, and a surge in digital diabetes prevention solutions, including virtual coaching, wearable devices, and AI-based metabolic monitoring. Governments and insurers are strengthening preventive care policies to reduce long-term healthcare costs. North America leads the market, while Asia-Pacific shows the fastest growth, driven by rising obesity and urbanization.

Key Takeaways
• 2024 Market Size: USD 14.62 Billion
• 2034 Forecast: USD 29.84 Billion
• CAGR: 7.2% (2025-2034)
• Strong demand for early diagnostics & preventive lifestyle programs
• Digital therapeutics playing a growing role in glucose management
• Asia-Pacific experiencing rapid rise in prediabetes population

Explore Full Report here:
https://exactitudeconsultancy.com/reports/72063/prediabetes-market

Market Drivers
• Increasing prevalence of obesity, sedentary behavior & metabolic syndrome
• Rising adoption of preventive care and diabetes risk screening
• Growing availability of pharmaceuticals for early glycemic control
• Expansion of digital diabetes prevention platforms
• Increased payer focus on reducing long-term diabetes-related costs

Segmentation Snapshot
By Treatment Type
• Lifestyle Modification Programs
• Antihyperglycemic Agents (Metformin, GLP-1, SGLT2 in select cases)
• Weight Management Therapies
• Digital Therapeutics & AI-Based Monitoring
• Nutritional Supplements & Medical Nutrition

By Diagnosis Method
• Fasting Plasma Glucose (FPG)
• HbA1c Testing
• Oral Glucose Tolerance Test (OGTT)
• Continuous Glucose Monitoring (CGM)
• Risk Assessment Screening Tools

By End User
• Hospitals
• Clinics
• Diagnostic Centers
• Digital Health Platforms
• Home Users

By Region
• North America (Largest Market)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72063

Recent Developments
• Growth in digital diabetes prevention programs backed by insurers.
• Advances in metabolic monitoring wearables & AI-driven risk scoring.
• Increased adoption of GLP-1 drugs for weight and glycemic control.
• Expansion of community-level diabetes screening initiatives.

Expert Quote - Irfan Tamboli, Business Development Executive
"Prediabetes intervention is becoming a global priority as healthcare systems shift toward prevention. Digital therapeutics, early diagnostics, and personalized metabolic programs are redefining how we address diabetes risk."

Conclusion
The Prediabetes Market is poised for significant growth through 2034 as early detection and preventive care become central to diabetes management. Companies focused on digital health platforms, metabolic monitoring tools, pharmaceutical interventions, and structured lifestyle programs will lead the next decade of innovation.
This report is also available in the following languages : Japanese (前糖尿病市場), Korean (전당뇨병 시장), Chinese (糖尿病前期市场), French (Marché du prédiabète), German (Prädiabetes-Markt), and Italian (Mercato del prediabete), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72063

Our More Reports:

Lennox Gastaut Syndrome Market
https://exactitudeconsultancy.com/reports/72091/lennox-gastaut-syndrome-market

Neuromyelitis optica spectrum disorder (NMOSD) Market
https://exactitudeconsultancy.com/reports/72093/neuromyelitis-optica-spectrum-disorder-nmosd-market

Spinocerebellar Ataxia (SCA) Market
https://exactitudeconsultancy.com/reports/72095/spinocerebellar-ataxia-sca-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.